Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline consisting of candidate therapeutics in Cutaneous T-Cell Lymphoma (CTCL), other oncology and adjunct cancer care, anti-infectives, stem cell therapy and unique prescription products.